GEN Exclusives

More »

GEN News Highlights

More »
Feb 22, 2007

Ikaria and Investor Group to Acquire INO Therapeutics for $670M

  • Ikaria Holdings will merge with INO Therapeutics in a transaction valued at approximately $670 million.

    INO Therapeutics is being acquired from The Linde Group, which will retain an equity position in the new entity. The combined company, which will be called Ikaria Holdings, will focus on therapeutic gases and critical care medicine. Its corporate headquarters will be in Clinton, NJ.

    "The merger of Ikaria and INO Therapeutics creates a fully integrated critical care therapeutics company with more than 300 employees, exceptional growth opportunities, and the capability to significantly improve critical care for newborns and other patients in thousands of hospitals around the world," says David Shaw, chairman and CEO-designate of the combined Ikaria entity.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?